600276

Jiangsu Hengrui Medicine
600276

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
CN¥325.11B
EV
CN¥300.70B
Shares Outstanding
6.36B
Beta
0.43

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
CN¥62.96
P/E 2025E
48.09x
P/Revenue 2025E
10.62x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Jiangsu Hengrui Medicine Co., Ltd.

gainify
600276

Jiangsu Hengrui Medicine Co., Ltd.

600276

Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, develops, manufactures, and commercializes drugs worldwide. The company is developing Camrelizumab, Pyrotinib, Fuzuloparib, Adebrelimab, Rezvilutamide, Famitinib, Dalpiciclib, SHR-1701, SHR-1501, SHR-A1811,...

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Dai, Hong Bin

Employees

20,238

IPO Date

2000-10-18

Headquarters

No. 38, Huanghe Road, Economic and Technological Development Zone, Lianyungang, Jiangsu Province, 222000, China

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved